Module 1: Screening and Diagnosis of Testosterone Deficiency Syndrome

PROGRAM GOAL

This activity seeks to provide a thorough understanding of the role of testosterone and its physiologic functions. With enhanced knowledge of the signs, symptoms, and associated clinical conditions of testosterone deficiency, primary care health professionals can better recognize the clinical manifestations of testosterone deficiency syndrome (TDS). Enhanced recognition of TDS and appropriate screening in men will greatly reduce underdiagnosis and improve disease management.

TARGET AUDIENCE

This learning activity is intended for a broad audience of healthcare practitioners including physicians, physician assistants, pharmacists, registered nurses, and nurse practitioners who are involved in the care of patients with testosterone deficiency.

TYPE OF ACTIVITY

Knowledge

LEARNING OBJECTIVES

As a result of participation in this activity, the participant will be better able to:

  1. Describe the mechanisms of production and the physiologic functions of testosterone
  2. Recognize the clinical manifestations of TDS
  3. Identify factors that may lead to variations in testosterone levels
  4. Identify candidates for testosterone screening and initiate appropriate tests for measurement
  5. Differentiate between primary and secondary hypogonadism

FACULTY

Alvaro Morales, MD, CM, FRCSC, FACS
Professor Emeritus
Department of Urology
Queen's University
Kingston, Ontario

Ronald Swerdloff, MD, MACP
Professor of Medicine
David Geffen School of Medicine at UCLA
Los Angeles, California
Chief, Division of Endocrinology, Metabolism & Nutrition
Harbor-UCLA Medical Center
Torrance, California

Module Overview

This module combines several multimedia offerings to provide a complete educational program on the screening and diagnosis of TDS.

  • A comprehensive and illustrated slide deck including expert slide notes, references, and links to PubMed articles for additional reading
  • A video presentation by an expert author reviews the key points presented in Module 1 of this program
  • An interactive algorithm, a clinical decision support tool for diagnostic purposes
  • A video case study with expert commentary
  • A narrated animation on the production, action, and clinical manifestations of testosterone in the aging male. It presents key learning points for the participant and can serve as a demonstration tool for healthcare professionals to use with their patients

Key Teaching Points

Through participation and interaction in this module, the participant will be introduced to the following key teaching points:

  • TDS is more common in individuals with comorbid conditions
  • Testosterone deficiency should be considered in men with commonly associated clinical conditions (eg, diabetes) and symptoms (eg, sexual dysfunction)
  • A combination of thorough history, physical examination, presence of signs/symptoms, and biochemical measurements is required for diagnosis of TDS
  • Use of appropriate testing can distinguish between primary and secondary hypogonadism
  • A triad of symptoms, biochemistry, and response to therapy is fundamental in confirming a diagnosis of TDS
  • Response to testosterone replacement therapy is important for continuation of treatment

Brought to you by


ACCREDITATION

This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council For Continuing Medical Education through the joint sponsorship of New York Medical College and Continuing Education Alliance. New York Medical College is accredited by the ACCME to provide continuing medical education for physicians.

New York Medical College designates this Enduring Material for a maximum of 1.5 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.


Continuing Education Alliance is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This program is approved for 1.5 contact hours (0.15 CEUs). Universal Activity Number 0270-9999-13-001-H01-P.

The estimated time to complete this activity is 1.5 hours.

Release date: August 23, 2013
Expiration date: August 23, 2014

This program is supported by an educational grant from AbbVie Inc.

The providers of this program have waived the processing fees.

FACULTY DISCLOSURES

All activity faculty and planners participating in continuing medical education activities sponsored by New York Medical College and Continuing Education Alliance are expected to disclose to the audience any significant support or substantial relationship(s) with providers of commercial products and/or devices discussed in their presentation and/or with any commercial supporters of the activity. In addition, all faculty are expected to openly disclose any off-label, experimental, or investigational use of drugs or devices discussed in their presentations.

The faculty and planning committee have been advised that this activity must be free from commercial bias, and based upon all the available scientifically rigorous data from research that conforms to accepted standards of experimental design, data collection, and analysis.

Dr Morales: advisory board/honoraria: Abbott Laboratories, Eli Lilly and Company; consultant: Abbott Laboratories, Bioniche Life Sciences Inc., Eli Lilly and Company.

Dr Swerdloff: consultant: Abbott Laboratories, Clarus Therapeutics; grant support: Clarus Therapeutics.

The Planning Committee for this activity included Margaret Astrologo and Kathy J. Kavanagh of New York Medical College; Ruth Cohen and Margaret Inman of Continuing Education Alliance; and David Searle of Prime Medic Inc. The members of the Planning Committee have no significant relationships to disclose.

DISCLAIMER

The opinions or views expressed in this CME/CPE activity do not necessarily reflect the opinions or recommendations of AbbVie Inc., Continuing Education Alliance, Mechanisms in Medicine Inc., or New York Medical College.

© 2013 Continuing Education Alliance. All Rights Reserved. CAE81413-1

How to Receive Credit

Participants wishing to earn CME/CPE credit must:

Successful completion of the self-assessment is required to earn CME/CPE credit. Successful completion is defined as a cumulative score of at least 70%. A certificate of credit will be automatically generated upon successful completion of the activity.

Technical Requirements



Developed by Prime Medic Inc. Copyright © 2013 Prime Medic Inc. All rights reserved.